Group One Trading’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,300
Closed -$76.8K 9167
2025
Q2
$76.8K Buy
11,300
+8,754
+344% +$62.2K ﹤0.01% 5204
2025
Q1
$24.4K Buy
2,546
+1,561
+158% +$17.7K ﹤0.01% 5685
2024
Q4
$10.7K Sell
985
-1,961
-67% -$25.3K ﹤0.01% 6070
2024
Q3
$53.6K Buy
2,946
+654
+29% +$13.4K ﹤0.01% 4617
2024
Q2
$65.3K Buy
2,292
+969
+73% +$41.9K ﹤0.01% 4310
2024
Q1
$67.3K Sell
1,323
-662
-33% -$33.4K ﹤0.01% 4462
2023
Q4
$114K Buy
+1,985
New +$94K ﹤0.01% 4350
2021
Q3
Sell
-415
Closed -$60K 8795
2021
Q2
$60K Buy
415
+407
+5,088% +$91.4K ﹤0.01% 6428
2021
Q1
$2K Sell
8
-43
-84% -$17.4K ﹤0.01% 7406
2020
Q4
$21K Buy
51
+47
+1,175% +$16.2K ﹤0.01% 5505
2020
Q3
$1K Sell
4
-72
-95% -$24.4K ﹤0.01% 5963
2020
Q2
$26K Sell
76
-38
-33% -$15.2K ﹤0.01% 4710
2020
Q1
$117K Buy
+114
New +$166K ﹤0.01% 3178
2017
Q3
Hold
0
-$2K 5167
2017
Q2
Hold
0
4587
2016
Q4
Sell
-8
Closed -$158K 4852
2016
Q3
$158K Buy
+8
New +$145K ﹤0.01% 2639
2016
Q2
Sell
-3
Closed -$79K 4953
2016
Q1
$79K Buy
+3
New +$63.4K ﹤0.01% 2985
2015
Q4
Hold
0
4259
2015
Q3
Sell
-1
Closed -$67.3K 4503
2015
Q2
$55K Sell
1
-1
-50% -$91.6K ﹤0.01% 3487
2015
Q1
$188K Buy
+2
New +$266K ﹤0.01% 2412

Other funds holding TPST

Group One Trading's TPST Position: Q2 2024 in Review

Group One Trading sold out of Tempest Therapeutics (TPST) in Q2 2024, closing a stake of 822 shares — an estimated $35.6K sold.

Group One Trading first reported a position in TPST in Q1 2015 and held it in 17 quarters. The position peaked at $945K in Q2 2015. 24 funds tracked by Wall St. Rank hold TPST as of Q2 2024.

  • Group One Trading reported no remaining Tempest Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 822 Tempest Therapeutics shares in Q2 2024, an estimated $35.6K.
  • Group One Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 17 quarters.
  • Group One Trading's Tempest Therapeutics position peaked at $945K in Q2 2015.
  • 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.